Title : The beneficial effects of reducing NLRP3 inflammasome activation in the cardiotoxicity and the anti-cancer effects of doxorubicin.

Pub. Date : 2021 Jan

PMID : 32852568






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The beneficial effects of reducing NLRP3 inflammasome activation in the cardiotoxicity and the anti-cancer effects of doxorubicin. Doxorubicin NLR family pyrin domain containing 3 Homo sapiens
2 Recent studies have suggested that the Nucleotide-Binding Domain-Like Receptor Protein 3 (NLRP3) inflammasome is implicated in tumor progression and the chemoresistance of cancer cells to DOX. Doxorubicin NLR family pyrin domain containing 3 Homo sapiens
3 Recent studies have suggested that the Nucleotide-Binding Domain-Like Receptor Protein 3 (NLRP3) inflammasome is implicated in tumor progression and the chemoresistance of cancer cells to DOX. Doxorubicin NLR family pyrin domain containing 3 Homo sapiens
4 Of interest, reducing NLRP3 inflammasome activity alleviates DOX-induced cardiotoxicity. Doxorubicin NLR family pyrin domain containing 3 Homo sapiens
5 Therefore, we postulate that strategies that target the NLRP3 inflammasome can help mitigate the cardiotoxic effects of DOX while maintaining and/or even enhancing its anti-cancer activity. Doxorubicin NLR family pyrin domain containing 3 Homo sapiens
6 Herein, we review the current knowledge about the potential implication of the NLRP3 inflammasome in the anti-cancer and cardiotoxic effects of DOX. Doxorubicin NLR family pyrin domain containing 3 Homo sapiens